ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01072812
Recruitment Status : Terminated (Business decision based on funding)
First Posted : February 22, 2010
Last Update Posted : April 22, 2015
Sponsor:
Information provided by (Responsible Party):
QR Pharma Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : July 2010
  Actual Study Completion Date : July 2010